In English | En español
Questions About Cancer? 1-800-4-CANCER

Find News Releases

Search For:
Between these dates:

Page Options

  • Print This Page
  • Email This Document
NCI in the News
  • Jury Still Out on Statins in Cancer
    MedPage Today

    (Posted: 04/16/2013) - Can statins, the widely used cholesterol-lowering drugs, play a role in cancer treatment? Three studies presented here this week at the annual meeting of the AACR suggest – at a casual glance – that the answer is Yes... Investigators led by Katherine McGlynn, PhD, of the National Cancer Institute in Bethesda, Md., used data from a large health maintenance organization to compare 75 liver cancer patients with 373 matched controls. In a univariate analysis, statin use was associated with a statistically significant 40% reduction in the risk of liver cancer.

  • New Clues to How Exercise May Reduce Breast Cancer Risk
    HealthDay

    (Posted: 04/11/2013) - Older women who are physically active have lower levels of estrogen and its breakdown products in their bodies, according to a new study, perhaps explaining why exercise may reduce breast cancer risk... The new study provides more clues as to how the exercise may be protective, said Cher Dallal, a cancer prevention fellow at the U.S. National Cancer Institute.

  • Melanoma Rates Rising in U.S. Children
    HealthDay

    (Posted: 04/04/2013) - While melanoma in children is still extremely rare, the rate increased by about 2 percent per year from 1973 to 2009 among U.S children from newborns to age 19...Recent studies have also shown that melanoma is on the rise among adults as well. Exactly what is driving these trends is not fully understood, but increased exposure to ultraviolet radiation from both the sun and tanning booths as well as greater awareness of melanoma may be responsible, according to study authors led by Jeannette Wong of the U.S. National Cancer Institute.

  • 18 Million Cancer Survivors Expected by 2022
    Time (subscription required)

    (Posted: 03/28/2013) - An aging population coupled with improved treatment methods mean more people will survive cancer. But at what cost? The American Association for Cancer Research released its second Annual Report on Cancer Survivorship, which shows that the current 13.7 million cancer survivors in the U.S. will likely swell by 31% to 18 million by the year 2022... “How to ensure that these patients lead not only long lives, but healthy and productive lives, will be a vital challenge to all of us,” said Julia Rowland, the director of the Office of Cancer Survivorship at the National Cancer Institute in a statement.

  • Women who ate more soy survive lung cancer better, study finds
    NBC News

    (Posted: 03/26/2013) - Soy foods, long shown to help lower the risk of cancer, may also help people survive at least some forms of cancer better. They found that Chinese women who ate the most soy were also less likely to die of lung cancer, the No. 1 cancer killer across the world. For the study, Gong Yang and colleagues at Vanderbilt University Medical Center, Shanghai Cancer Institute, and the National Cancer Institute looked at data from a large study of Chinese women called the Shanghai Women’s Health Study.

  • Widespread Flaws Found in Ovarian Cancer Treatment
    New York Times (subscription required)

    (Posted: 03/12/2013) - Most women with ovarian cancer receive inadequate care and miss out on treatments that could add a year or more to their lives, a new study has found...The National Cancer Institute took a rare step, one it reserves for major advances. It issued a “clinical announcement” to encourage doctors to use the IP treatment, and to urge patients to ask about it.

  • Study Sees More Breast Cancer at Young Age
    New York Times (subscription required)

    (Posted: 02/27/2013) - The incidence of advanced breast cancer among younger women, ages 25 to 39, may have increased slightly over the last three decades, according to a study released Tuesday. But more research is needed to verify the finding, which was based on an analysis of statistics, the study’s authors said. They do not know what may have caused the apparent increase... The researchers analyzed data from SEER, a program run by the National Cancer Institute to collect cancer statistics on 28 percent of the population of the United States.

  • Burkitt lymphoma risk after transplantation highlighted
    MedwireNews

    (Posted: 02/13/2013) - Solid organ transplant recipients have a significant risk for developing Burkitt lymphoma (BL), US researchers have found. Transplant recipients in the USA are 23 times more likely to develop BL than members of the general population, with an incidence of 10.8 cases per 100,000 person-years, say Sam Mbulaiteye, NCI, and co-authors.

  • Cancer deaths fall for African-American men, disparities remain
    CNN

    (Posted: 02/06/2013) - The latest report on cancer among African-Americans shows a good-news, bad-news scenario. While racial gaps are closing for some types of cancers, including fewer cancer deaths among African-American men, disparities are increasing for some cancers that can be found through routine screenings. Every two years, the American Cancer Society reports on the latest data, based on reports from NCI, CDC, and NAACCR. The newest information includes data for the year 2009.

  • How Effective Are Routine Mammograms at Delaying Death?
    PBS Newshour

    (Posted: 12/26/2012) - We've asked three of the nation's most influential doctors whether women over the age of 40 should be screened yearly. Dr. Sandra Swain of the American Society of Clinical Oncology, says yes. Dr. Archie Bleyer, co-author of the New England Journal of Medicine report, says no. And below, Dr. Barnett Kramer, director of the National Cancer Institute's Division of Cancer Prevention, explains the scientific basis for both arguments.

1 2 3 4  Next >